A detailed history of R Squared LTD transactions in Cerus Corp stock. As of the latest transaction made, R Squared LTD holds 55,760 shares of CERS stock, worth $67,469. This represents 0.04% of its overall portfolio holdings.

Number of Shares
55,760
Previous 38,655 44.25%
Holding current value
$67,469
Previous $53.7 Million 46.33%
% of portfolio
0.04%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025

BUY
$1.22 - $1.51 $20,868 - $25,828
17,105 Added 44.25%
55,760 $78.6 Million
Q1 2025

May 09, 2025

BUY
$1.39 - $2.15 $27,737 - $42,903
19,955 Added 106.71%
38,655 $53.7 Million
Q4 2024

Jan 22, 2025

BUY
$1.52 - $2.03 $28,424 - $37,960
18,700 New
18,700 $28.8 Million

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $214M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track R Squared LTD Portfolio

Follow R Squared LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of R Squared LTD, based on Form 13F filings with the SEC.

News

Stay updated on R Squared LTD with notifications on news.